Holen Sie sich die Stockscreener-App
134.55
0.07%
0.10
Apogee Therapeutics Inc Aktie (APGE) Neueste Nachrichten
Apogee Therapeutics Inc. (NASDAQ:APGE) Receives Consensus Recommendation of "Hold" from Analysts - marketbeat.com
Handelsbanken Fonder AB Has $11.46 Million Stake in Apogee Therapeutics Inc. $APGE - marketbeat.com
This Apogee Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Sahm
Apogee Therapeutics, Inc. (APGE) Stock Price, News, Quote & History - Yahoo Finance
Apogee Therapeutics Director Vote: My Take On The 8-K Liga Mx (YjhKcvC1lD) - Mshale
Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by BTIG Research - marketbeat.com
APGE Downgraded by BTIG -- Rating Changed to Neutral - GuruFocus
BTIG Downgrades Apogee Therapeutics to Neutral From Buy - marketscreener.com
BTIG downgrades Apogee Therapeutics stock rating after AbbVie deal - Investing.com Nigeria
Apogee Therapeutics Directors Execute Stock Options, Increasing Holdings - Kalkine Media
Apogee Therapeutics (APGE): Fairmount-linked funds exercise 42,208 options - Stock Titan
Apogee Therapeutics, Inc. Announces Board and Committee Changes - marketscreener.com
Apogee Therapeutics,Q2 2026 Net Loss $85.9 - Moomoo
My Takeaway On Apogee Therapeutics' Massive Cash Raise Humberto Cruz (GVA0ZiS739) - Mshale
APGE SWOT Analysis: Financial Resilience Amidst Clinical Challenges Revealed in 10-Q Filing - GuruFocus
Apogee Therapeutics Reports Q2 2026 Results and Announces Merger Agreement with AbbVie Subsidiary - Kalkine Media
Apogee Therapeutics 2Q 2026: Net loss $85.9M, First half loss $160M — 10-Q Summary - TradingView
Apogee Therapeutics (APGE) details Q2 2026 losses, AbbVie merger plan and $100M BXLS deal - Stock Titan
Apogee Therapeutics (NASDAQ:APGE) Issues Earnings Results, Misses Expectations By $1.00 EPS - marketbeat.com
Apogee Therapeutics Q2 Loss Widens - marketscreener.com
Earnings Flash (APGE) Apogee Therapeutics Posts Q2 Net Loss $85.9M, vs. FactSet Est of $78.7M Loss - marketscreener.com
Apogee reports $85.9 million Q2 loss as AbbVie deal advances - Quiver Quantitative
Apogee Therapeutics reports Q2 2026 results; cash and marketable securities $1.3B, net loss $85.9M - TradingView
Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates - GlobeNewswire
Apogee Therapeutics Inc. $APGE Shares Acquired by Bank of America Corp DE - marketbeat.com
AbbVie Plans $10.6 Billion Acquisition of Apogee Therapeutics - Intellectia AI
Apogee Therapeutics CMO Carl Dambkowski sells $737,934 in shares By Investing.com - Investing.com India
Apogee Therapeutics CMO Carl Dambkowski disposes of USD 737,935 in common shares - Bitget
Apogee Therapeutics (APGE) CMO trades stock under 10b5-1 plan - Stock Titan
Apogee Therapeutics CMO Carl Dambkowski sells $737,934 in shares - Investing.com
Apogee Therapeutics (NASDAQ:APGE) Insider Carl Dambkowski Sells 5,500 Shares - marketbeat.com
Sei Investments Co. Grows Stock Holdings in Apogee Therapeutics Inc. $APGE - marketbeat.com
Apogee Therapeutics stock hits all-time high at 134.47 USD By Investing.com - Investing.com Nigeria
Apogee Therapeutics stock hits all-time high at 134.47 USD - Investing.com
APGE, Apogee Therapeutics, Inc., 2025-03-11, Stock Prices And MACD Indicators #MACD #APGE Al Nassr (6zlIIYGDqA) - Mshale
Apogee Therapeutics (NASDAQ:APGE) Sets New 52-Week HighWhat's Next? - marketbeat.com
First Trust Advisors LP Grows Stock Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics Inc. $APGE Shares Sold by The Manufacturers Life Insurance Company - marketbeat.com
Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout - Yahoo Finance
AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal - Bloomberg.com
Apogee Therapeutics, Inc. (APGE) Stock Analysis: Navigating the Biotech Landscape with a $10 Billion Market Cap - DirectorsTalk Interviews
Is Apogee Therapeutics (APGE) Fully Priced, Or Still A Bargain? - Yahoo Finance
Apogee Therapeutics (APGE) to Post Quarterly Earnings on Monday - marketbeat.com
Weekly Recap: APGE sale probe and zumilokibart efficacy - TradingView
Perceptive Advisors LLC Has $129.65 Million Stock Holdings in Apogee Therapeutics Inc. $APGE - marketbeat.com
Apogee Therapeutics, Inc. Revenue Breakdown – NASDAQ:APGE - TradingView
AbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates - Reuters
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc.APGE - Business Wire
Swiss National Bank Has $6.36 Million Position in Apogee Therapeutics Inc. $APGE - marketbeat.com
Is Apogee Therapeutics Inc. (APGE) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
APGE|Apogee Therapeutics Inc|Price:134.310|Chg%:+0.030 - TradingKey
Apogee Therapeutics Inc (APGE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Apogee Therapeutics Inc (APGE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apogee Therapeutics (NASDAQ:APGE) Sets New 12-Month HighHere's Why - marketbeat.com
Apogee Therapeutics Inc (APGE) Institutional Confidence - TradingKey
TradingKey - TradingKey
Apogee Therapeutics Inc (APGE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apogee Therapeutics Inc (APGE) Income Statement - TradingKey
Apogee Therapeutics Inc (APGE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apogee Therapeutics Inc (APGE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
APGE|Apogee Therapeutics Inc|Price:134.310| - TradingKey
Why Wall Street Can't Get Enough of This Dividend King - The Motley Fool
Apogee Therapeutics Inc (APGE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Form 4 Apogee Therapeutics Inc For: 24 July By Investing.com - Investing.com South Africa
Granahan Investment Management LLC Has $6.32 Million Stock Position in Apogee Therapeutics Inc. $APGE - marketbeat.com
Apogee Therapeutics (APGE) CFO makes bona fide gift of 15,000 shares - Stock Titan
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):